Website News and Research

RSS

GAVI says pentavalent vaccine price to fall, but $3.7B still needed to vaccinate children in developing countries

The average price of a vaccine that protects children against five diseases is expected to "drop to $2.58 next year compared to the current average price of $2.97," the GAVI Alliance said Friday, Reuters reports. The group credits the expected price decline, which "represents a decrease of 30 percent over the last seven years," in part to an "increased demand for the pentavalent, or five-in-one vaccine," according to the news service (Kelland, 11/26).

30 Nov 2010

Array BioPharma to present data on ARRY-520 Phase 1 trial for multiple myeloma at ASH Annual Meeting

Array BioPharma Inc. today announced that it will present data from a Phase 1 trial of KSP inhibitor ARRY-520 in patients with relapsed/refractory multiple myeloma at the 2010 Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida on Saturday, December 4, 2010.

30 Nov 2010

Calistoga to feature data on CAL-101 inhibitor for hematologic malignancies at ASH Annual Meeting

Calistoga Pharmaceuticals, Inc., the leader in the development of delta-isoform-selective phosphatidylinositol 3-kinase (PI3K-delta) inhibitors for the treatment of cancer and inflammatory diseases, today announced the upcoming presentation of clinical and preclinical results supporting the clinical benefit of CAL-101, an oral, PI3K-delta inhibitor, in the treatment of patients with hematologic malignancies.

30 Nov 2010

Golden Valley acquires Digit-Pro and Cut Stop

Golden Valley Development, Inc. is pleased to announce that it has recently completed the acquisition of two new companies, each having a licensing agreement to manufacture and market a new patented technology.

29 Nov 2010

BioTime, CIRM enter agreement for GMP-grade hES cell lines

BioTime, Inc. today announced an agreement with the California Institute for Regenerative Medicine (CIRM) to make five clinical-grade human embryonic stem (hES) cell lines available to California-based researchers. CIRM is the stem cell agency created when California voters supported a $3 billion funding measure for stem cell-related research and clinical translation.

29 Nov 2010

New findings provide insight into brain development

St. Jude Children's Research Hospital investigators have identified key components of a signaling pathway that controls the departure of neurons from the brain niche where they form and allows these cells to start migrating to their final destination. Defects in this system affect the architecture of the brain and are associated with epilepsy, mental retardation and perhaps malignant brain tumors.

25 Nov 2010

Boston Uni/Boston Medical Center establishes registry for people interested in participating in research studies

Boston University/Boston Medical Center (BU/ BMC) has established a registry to provide an easy way to connect researchers who are looking for research volunteers with people who are looking for studies to join. The registry, named ReSPECT (Recruitment Services Program of the Clinical & Translational Science Institute), is a free service.

24 Nov 2010

Headline-grabbing offers may not best meet needs of Medicare Part D plan enrollees

National Community Pharmacists Association (NCPA) Executive Vice President and CEO Kathleen Jaeger issued the following statement today in response to the Avalere Health study analyzing how the formulary and cost-sharing benefits changes made by various Medicare Part D prescription drug plans affect seniors:

24 Nov 2010

Revolutions Medical demonstrates new market samples of 3ml RevVac Safety syringe

Revolutions Medical met with interested global distributors and showed, for the first time, the new market samples of its 3ml RevVac Safety syringe.

24 Nov 2010

UnitedHealthcare introduces Pharmacy Saver program to provide affordable prescription drugs

UnitedHealthcare, a UnitedHealth Group company, announced a new program that will enable enrollees in the company's market-leading Medicare plans to save money on hundreds of prescription medications in 2011.

23 Nov 2010

CCSA releases Portfolio of Canadian Standards for Youth Substance Abuse Prevention

Schools, families and community practitioners now have a practical prevention resource guide to help prevent and stop youth from using drugs.

23 Nov 2010

Implanted devices to treat cardiac dysfunction show success in real world use

Implanted devices that treat cardiac dysfunction in heart failure patients are as successful in "real world" use as they are in controlled clinical trial settings, according to a large new study reported in Circulation: Journal of the American Heart Association.

23 Nov 2010

Asbestos awareness important to prevent related cancer: Experts

Experts from Perth speculate Western Australia is yet to see the peak of asbestos-induced cancer, with renovators still failing to take proper precautions. According to director of the National Centre for Asbestos Related Diseases, Bruce Robinson, the next and third wave of mesothelioma patients would come out of those putting themselves and others at risk while taking on DIY home renovation projects.

22 Nov 2010

Patient Safety Technologies third quarter revenues increase to $4.1 million

Patient Safety Technologies, Inc. today announced financial results for its third quarter of 2010 and for the nine months ended September 30, 2010.

22 Nov 2010

Pfizer subsidiary extends tender offer for King acquisition

Pfizer Inc. today announced that its wholly-owned subsidiary, Parker Tennessee Corp., has extended the expiration date of its tender offer for all outstanding shares of common stock of King Pharmaceuticals, Inc. for $14.25 per share, net to the seller in cash, without interest thereon and subject to any required withholding taxes.

22 Nov 2010

DaVita announces meal planning tool for dialysis patients

DaVita Inc., a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease (CKD), offers patients with very restricted diets an easy to use meal planning tool and recipes for their favorite Thanksgiving dinners at DaVita.com.

22 Nov 2010

Alexion's Soliris Phase 2 clinical study for aHUS meets primary, secondary endpoints

Alexion Pharmaceuticals, Inc. announced today that a Phase 2 clinical study investigating Soliris (eculizumab) as a treatment for patients with atypical Hemolytic Uremic Syndrome (aHUS) who are resistant to plasma therapy met primary and key secondary endpoints with high levels of statistical and clinical significance, according to results presented today at the American Society of Nephrology (ASN) annual meeting in Denver.

21 Nov 2010

NCI’s website helps women to live a smoke-free life

Are you ready to quit smoking and willing to share the good, bad, and ugly about your experience If so, the National Cancer Institute (NCI) wants to feature you on their Smokefree Women Web site as part of the Women Who Quit campaign.

20 Nov 2010

Russian-trained microbiologist recommends tips for consumers to achieve effective results from probiotics

With the European Union poised to regulate probiotics, and with probiotic supplement sales increasing dramatically in the United States, Americans need to know what they're buying, and how these products can affect their health.

20 Nov 2010

CVS Caremark Customer Care team ranked second in the world for Best Customer Service

CVS Caremark's Pharmacy Benefit Management Customer Care team was ranked second in the world for Best Customer Service with an Internal Contact Center by Contact Center World at the organization's Global Top Ranking Performers Awards Conference in Las Vegas. The awards recognize the best in the contact center industry worldwide.

20 Nov 2010

Website News and Research

GAVI says pentavalent vaccine price to fall, but $3.7B still needed to vaccinate children in developing countries

Array BioPharma to present data on ARRY-520 Phase 1 trial for multiple myeloma at ASH Annual Meeting

Calistoga to feature data on CAL-101 inhibitor for hematologic malignancies at ASH Annual Meeting

Golden Valley acquires Digit-Pro and Cut Stop

BioTime, CIRM enter agreement for GMP-grade hES cell lines

New findings provide insight into brain development

Boston Uni/Boston Medical Center establishes registry for people interested in participating in research studies

Headline-grabbing offers may not best meet needs of Medicare Part D plan enrollees

Revolutions Medical demonstrates new market samples of 3ml RevVac Safety syringe

UnitedHealthcare introduces Pharmacy Saver program to provide affordable prescription drugs

CCSA releases Portfolio of Canadian Standards for Youth Substance Abuse Prevention

Implanted devices to treat cardiac dysfunction show success in real world use

Asbestos awareness important to prevent related cancer: Experts

Patient Safety Technologies third quarter revenues increase to $4.1 million

Pfizer subsidiary extends tender offer for King acquisition

DaVita announces meal planning tool for dialysis patients

Alexion's Soliris Phase 2 clinical study for aHUS meets primary, secondary endpoints

NCI’s website helps women to live a smoke-free life

Russian-trained microbiologist recommends tips for consumers to achieve effective results from probiotics

CVS Caremark Customer Care team ranked second in the world for Best Customer Service

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News